Loading...
The SARS-CoV-2 RNA-protein interactome in infected human cells.
Schmidt, Nora ; Lareau, Caleb A ; Keshishian, Hasmik ; Ganskih, Sabina ; Schneider, Cornelius ; Hennig, Thomas ; Melanson, Randy ; Werner, Simone ; Wei, Yuanjie ; Zimmer, Matthias ... show 10 more
Schmidt, Nora
Lareau, Caleb A
Keshishian, Hasmik
Ganskih, Sabina
Schneider, Cornelius
Hennig, Thomas
Melanson, Randy
Werner, Simone
Wei, Yuanjie
Zimmer, Matthias
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2020-12-21
Submitted date
Files
Loading...
Open Access publication
Adobe PDF, 4.02 MB
Other Titles
Abstract
Characterizing the interactions that SARS-CoV-2 viral RNAs make with host cell proteins during infection can improve our understanding of viral RNA functions and the host innate immune response. Using RNA antisense purification and mass spectrometry, we identified up to 104 human proteins that directly and specifically bind to SARS-CoV-2 RNAs in infected human cells. We integrated the SARS-CoV-2 RNA interactome with changes in proteome abundance induced by viral infection and linked interactome proteins to cellular pathways relevant to SARS-CoV-2 infections. We demonstrated by genetic perturbation that cellular nucleic acid-binding protein (CNBP) and La-related protein 1 (LARP1), two of the most strongly enriched viral RNA binders, restrict SARS-CoV-2 replication in infected cells and provide a global map of their direct RNA contact sites. Pharmacological inhibition of three other RNA interactome members, PPIA, ATP1A1, and the ARP2/3 complex, reduced viral replication in two human cell lines. The identification of host dependency factors and defence strategies as presented in this work will improve the design of targeted therapeutics against SARS-CoV-2.
Citation
Nat Microbiol. 2020 Dec 21. doi: 10.1038/s41564-020-00846-z. Epub ahead of print.
Publisher
Journal
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
EISSN
2058-5276
ISBN
ISMN
Gov't Doc #
Sponsors
License
Attribution 4.0 International
